Based on these findings, it is foreseeable that under conditions of selective LMP7 inhibition in the TME of TNBC/IBC, the activity of the remaining IP subunits LMP2 and MECL1 may be sufficient for the generation of peptides for antigen presentation and activation of CD8+ T cells. This evidence concerns the gene PSMB10 and inflammatory breast carcinoma.